A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”
Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …
Read More »Could a Stool Test Predict Your Patient’s Best Diabetes Medication?
Could a stool sample someday help clinicians choose a diabetes medication before writing the prescription? Emerging research into gut biomarkers in diabetes is moving that possibility closer to clinical reality. Rather than simply cataloging which bacteria live in the intestine, researchers are examining microbial genes, stool-derived metabolites, and functional signatures …
Read More »GLP-1s and the Gut Microbiome: Emerging Insights Into Gut–Metabolic Interactions
The conversation around GLP-1 therapies has shifted quickly. While most clinicians focus on weight loss and glucose lowering, new data on GLP-1 microbiome effects suggest something deeper may be happening in the gut. Could these medications reshape the intestinal ecosystem in ways that support long-term metabolic health? Increasingly, researchers believe …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.